stars 1 stars 2 stars 3

MyEnterix has pioneered a patch clamp recording technique of in situ human intestinal neurons (EnteroPatch®) EnteroPatch is the first routine technique available at investigating the human nervous system. MyEnterix is a Biotech company created in 2012 which offers: - a unique model of living human neuron to his customers drug and target validation on human neurons as early as preclinical phase - enteric neuronal assays to probe “medical food” and probiotic efficiencies Thanks to its leading team of scientists with an outstanding experience in electrophysiology, pharmacology and cell biology, MyEnterix offers comprehensive integrated services on gastro-intestinal discovery.

MyEnterix Questions

The MyEnterix annual revenue was $200000 in 2026.

Eric di Pasquale is the Founder, Director R and D of MyEnterix.

1 people are employed at MyEnterix.

MyEnterix is based in Marseille, Provence-Alpes-Cote d'Azur.

The NAICS codes for MyEnterix are [325, 3254, 32].

The SIC codes for MyEnterix are [283, 28].

Top MyEnterix Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users